Klaus J Olsen

Alpha-mannosidosis: correlation between phenotype, genotype and mutant MAN2B1 subcellular localisation

Line Borgwardt, Hilde Monica Frostad Riise Stensland, Klaus J Olsen et al. · Orphanet Journal of Rare Diseases · 2015 · 59 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial

Luis Rivera, Rasmus S. Pedersen, Lourdes Peña et al. · The Lancet Infectious Diseases · 2017 · 16 citations · Full text

Veterinary Medicine, Infectious Diseases, Pediatrics +17

First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12 months and 5 years of age

Line M. Lindgren, Pernille N. Tingskov, Annette H. Justesen et al. · Vaccine · 2016 · 10 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17